Production, characterization and toxicology assay of creatine pegylated nanoliposome with polysorbate 80 for brain delivery

Detalhes bibliográficos
Autor(a) principal: BORIN,DIEGO B.
Data de Publicação: 2018
Outros Autores: MEZZOMO,NATHANA J., VAUCHER,RODRIGO A., CARMO,GUILHERME DO, RODRIGUES JUNIOR,LUIZ C., SULCZEWSKI,FERNANDO B., SCHWERTZ,CLAITON I., MENDES,RICARDO E., DAMIANI,ADRIANI P., ANDRADE,VANESSA M. DE, RECH,VIRGÍNIA C., BOECK,CARINA R.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Anais da Academia Brasileira de Ciências (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0001-37652018000502317
Resumo: ABSTRACT Creatine acts intracellularly as energy buffer and storage, demonstrating protective effects in animal models of neurodegenerative diseases. However, its permeability throught blood-brain barrier (BBB) is reduced. The aim of the present study was developing a carrier to facilitate the delivery of creatine to the central nervous system. Creatine nanoliposomes were produced, characterized and assayed in models of toxicity in vitro and in vivo. Particles showed negative zeta potential (-12,5 mV), polydispersity index 0.237 and medium-size of 105 nm, which was confirmed by transmission electron microscopy (TEM) images. Toxicity assay in vitro was evaluated with blank liposomes (no drug) or creatine nanoliposomes at concentrations of 0.02 and 0.2 mg/mL, that did not influence the viability of Vero cells. The result. of the comet assay that the nanoliposomes are not genotoxic, togeher with cell viability demonstrated that the nanoliposomes are not toxic. Besides, in vivo assays not demonstrate toxicity in hematological and biochemical markers of young rats. Nevertheless, increase content of creatine in the cerebral cortex tissue after subchronic treatment was observed. Altogether, results indicate increase permeability of creatine to the BBB that could be used as assay for in vivo studies to confirm improved effect than free creatine.
id ABC-1_d25df82c747c9353762017bbc241edbc
oai_identifier_str oai:scielo:S0001-37652018000502317
network_acronym_str ABC-1
network_name_str Anais da Academia Brasileira de Ciências (Online)
repository_id_str
spelling Production, characterization and toxicology assay of creatine pegylated nanoliposome with polysorbate 80 for brain deliverynanocarrierneurodegenerative diseasesnanotechnologyliposomesABSTRACT Creatine acts intracellularly as energy buffer and storage, demonstrating protective effects in animal models of neurodegenerative diseases. However, its permeability throught blood-brain barrier (BBB) is reduced. The aim of the present study was developing a carrier to facilitate the delivery of creatine to the central nervous system. Creatine nanoliposomes were produced, characterized and assayed in models of toxicity in vitro and in vivo. Particles showed negative zeta potential (-12,5 mV), polydispersity index 0.237 and medium-size of 105 nm, which was confirmed by transmission electron microscopy (TEM) images. Toxicity assay in vitro was evaluated with blank liposomes (no drug) or creatine nanoliposomes at concentrations of 0.02 and 0.2 mg/mL, that did not influence the viability of Vero cells. The result. of the comet assay that the nanoliposomes are not genotoxic, togeher with cell viability demonstrated that the nanoliposomes are not toxic. Besides, in vivo assays not demonstrate toxicity in hematological and biochemical markers of young rats. Nevertheless, increase content of creatine in the cerebral cortex tissue after subchronic treatment was observed. Altogether, results indicate increase permeability of creatine to the BBB that could be used as assay for in vivo studies to confirm improved effect than free creatine.Academia Brasileira de Ciências2018-08-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0001-37652018000502317Anais da Academia Brasileira de Ciências v.90 n.2 suppl.1 2018reponame:Anais da Academia Brasileira de Ciências (Online)instname:Academia Brasileira de Ciências (ABC)instacron:ABC10.1590/0001-3765201820170553info:eu-repo/semantics/openAccessBORIN,DIEGO B.MEZZOMO,NATHANA J.VAUCHER,RODRIGO A.CARMO,GUILHERME DORODRIGUES JUNIOR,LUIZ C.SULCZEWSKI,FERNANDO B.SCHWERTZ,CLAITON I.MENDES,RICARDO E.DAMIANI,ADRIANI P.ANDRADE,VANESSA M. DERECH,VIRGÍNIA C.BOECK,CARINA R.eng2019-11-29T00:00:00Zoai:scielo:S0001-37652018000502317Revistahttp://www.scielo.br/aabchttps://old.scielo.br/oai/scielo-oai.php||aabc@abc.org.br1678-26900001-3765opendoar:2019-11-29T00:00Anais da Academia Brasileira de Ciências (Online) - Academia Brasileira de Ciências (ABC)false
dc.title.none.fl_str_mv Production, characterization and toxicology assay of creatine pegylated nanoliposome with polysorbate 80 for brain delivery
title Production, characterization and toxicology assay of creatine pegylated nanoliposome with polysorbate 80 for brain delivery
spellingShingle Production, characterization and toxicology assay of creatine pegylated nanoliposome with polysorbate 80 for brain delivery
BORIN,DIEGO B.
nanocarrier
neurodegenerative diseases
nanotechnology
liposomes
title_short Production, characterization and toxicology assay of creatine pegylated nanoliposome with polysorbate 80 for brain delivery
title_full Production, characterization and toxicology assay of creatine pegylated nanoliposome with polysorbate 80 for brain delivery
title_fullStr Production, characterization and toxicology assay of creatine pegylated nanoliposome with polysorbate 80 for brain delivery
title_full_unstemmed Production, characterization and toxicology assay of creatine pegylated nanoliposome with polysorbate 80 for brain delivery
title_sort Production, characterization and toxicology assay of creatine pegylated nanoliposome with polysorbate 80 for brain delivery
author BORIN,DIEGO B.
author_facet BORIN,DIEGO B.
MEZZOMO,NATHANA J.
VAUCHER,RODRIGO A.
CARMO,GUILHERME DO
RODRIGUES JUNIOR,LUIZ C.
SULCZEWSKI,FERNANDO B.
SCHWERTZ,CLAITON I.
MENDES,RICARDO E.
DAMIANI,ADRIANI P.
ANDRADE,VANESSA M. DE
RECH,VIRGÍNIA C.
BOECK,CARINA R.
author_role author
author2 MEZZOMO,NATHANA J.
VAUCHER,RODRIGO A.
CARMO,GUILHERME DO
RODRIGUES JUNIOR,LUIZ C.
SULCZEWSKI,FERNANDO B.
SCHWERTZ,CLAITON I.
MENDES,RICARDO E.
DAMIANI,ADRIANI P.
ANDRADE,VANESSA M. DE
RECH,VIRGÍNIA C.
BOECK,CARINA R.
author2_role author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv BORIN,DIEGO B.
MEZZOMO,NATHANA J.
VAUCHER,RODRIGO A.
CARMO,GUILHERME DO
RODRIGUES JUNIOR,LUIZ C.
SULCZEWSKI,FERNANDO B.
SCHWERTZ,CLAITON I.
MENDES,RICARDO E.
DAMIANI,ADRIANI P.
ANDRADE,VANESSA M. DE
RECH,VIRGÍNIA C.
BOECK,CARINA R.
dc.subject.por.fl_str_mv nanocarrier
neurodegenerative diseases
nanotechnology
liposomes
topic nanocarrier
neurodegenerative diseases
nanotechnology
liposomes
description ABSTRACT Creatine acts intracellularly as energy buffer and storage, demonstrating protective effects in animal models of neurodegenerative diseases. However, its permeability throught blood-brain barrier (BBB) is reduced. The aim of the present study was developing a carrier to facilitate the delivery of creatine to the central nervous system. Creatine nanoliposomes were produced, characterized and assayed in models of toxicity in vitro and in vivo. Particles showed negative zeta potential (-12,5 mV), polydispersity index 0.237 and medium-size of 105 nm, which was confirmed by transmission electron microscopy (TEM) images. Toxicity assay in vitro was evaluated with blank liposomes (no drug) or creatine nanoliposomes at concentrations of 0.02 and 0.2 mg/mL, that did not influence the viability of Vero cells. The result. of the comet assay that the nanoliposomes are not genotoxic, togeher with cell viability demonstrated that the nanoliposomes are not toxic. Besides, in vivo assays not demonstrate toxicity in hematological and biochemical markers of young rats. Nevertheless, increase content of creatine in the cerebral cortex tissue after subchronic treatment was observed. Altogether, results indicate increase permeability of creatine to the BBB that could be used as assay for in vivo studies to confirm improved effect than free creatine.
publishDate 2018
dc.date.none.fl_str_mv 2018-08-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0001-37652018000502317
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0001-37652018000502317
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/0001-3765201820170553
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Academia Brasileira de Ciências
publisher.none.fl_str_mv Academia Brasileira de Ciências
dc.source.none.fl_str_mv Anais da Academia Brasileira de Ciências v.90 n.2 suppl.1 2018
reponame:Anais da Academia Brasileira de Ciências (Online)
instname:Academia Brasileira de Ciências (ABC)
instacron:ABC
instname_str Academia Brasileira de Ciências (ABC)
instacron_str ABC
institution ABC
reponame_str Anais da Academia Brasileira de Ciências (Online)
collection Anais da Academia Brasileira de Ciências (Online)
repository.name.fl_str_mv Anais da Academia Brasileira de Ciências (Online) - Academia Brasileira de Ciências (ABC)
repository.mail.fl_str_mv ||aabc@abc.org.br
_version_ 1754302866539937792